Imaging nigral pathology and clinical progression in Parkinson's disease. - Wikidata - awgldk - TriplyDB

Imaging nigral pathology and clinical progression in Parkinson's disease.

Imaging nigral pathology and clinical progression in Parkinson's disease.

http://www.wikidata.org/entity/Q36434577

about

The perplexing paradox of paraquat: the case for host-based susceptibility and postulated neurodegenerative effects Microstructural changes in the substantia nigra of asymptomatic agricultural workers The evolving role of diffusion magnetic resonance imaging in movement disorders MRI reveals brain abnormalities in drug-naive Parkinson's disease.Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study.Free-water imaging in Parkinson's disease and atypical parkinsonism.Why psychosis is frequently associated with Parkinson's disease?A Method for Automated Classification of Parkinson's Disease Diagnosis Using an Ensemble Average Propagator Template Brain Map Estimated from Diffusion MRI.Chemical Exchange Saturation Transfer MR Imaging is Superior to Diffusion-Tensor Imaging in the Diagnosis and Severity Evaluation of Parkinson's Disease: A Study on Substantia Nigra and Striatum.Parkinson's disease biomarkers program brain imaging repository.Parkinson's disease diffusion MRI is not affected by acute antiparkinsonian medication.The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.Region-Specific Iron Measured by MRI as a Biomarker for Parkinson's Disease.Diffusion Kurtosis Imaging of Substantia Nigra Is a Sensitive Method for Early Diagnosis and Disease Evaluation in Parkinson's Disease.Stage-dependent loss of cortical gyrification as Parkinson disease "unfolds"The pattern of gray matter atrophy in Parkinson's disease differs in cortical and subcortical regions Combining Diffusion Tensor Imaging and Susceptibility Weighted Imaging on the Substantia Nigra of 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine (MPTP)-induced Rhesus Monkey Model of Parkinson's Disease.Combined Diffusion Tensor Imaging and Arterial Spin Labeling as Markers of Early Parkinson's disease.Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis.Dopamine overdose hypothesis: evidence and clinical implications.T2-relaxometry predicts outcome of DBS in idiopathic Parkinson's disease.Multi-atlas segmentation of subcortical brain structures via the AutoSeg software pipeline.Quantitative susceptibility mapping of the midbrain in Parkinson's disease Microstructural Changes within the Basal Ganglia Differ between Parkinson Disease Subtypes.Diffusion tensor imaging in Parkinson's disease: Review and meta-analysis Lateralized basal ganglia vulnerability to pesticide exposure in asymptomatic agricultural workers.Functional MRI of disease progression in Parkinson disease and atypical parkinsonian syndromes In vivo detection of lateral-ventral tier nigral degeneration in Parkinson's disease.Neuroimaging in Parkinson's disease: a future perspective.Magnetic resonance imaging for the diagnosis of Parkinson's disease.Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping.Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease.T2* Relaxometry in Patients with Parkinson's Disease : Use of an Automated Atlas-based Approach.Fractional anisotropy in the substantia nigra in Parkinson's disease: a complex picture.UNC-Utah NA-MIC framework for DTI fiber tract analysis.Neurite orientation dispersion and density imaging in the substantia nigra in idiopathic Parkinson disease.Combined Diffusion Tensor Imaging and Apparent Transverse Relaxation Rate Differentiate Parkinson Disease and Atypical Parkinsonism.Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits.Differential involvement of nigral subregions in idiopathic parkinson's disease.Progression marker of Parkinson's disease: a 4-year multi-site imaging study.

P2860

Q28396222-A9C01F3C-B877-4ED8-859D-AAE145FDD1E4 Q28397004-B70316D7-724A-4F17-B73C-B082A6763BDF Q30667544-3EA02352-486D-42C4-85FF-C9D426F28137 Q30688718-E76F87FB-DEAB-40F1-9E40-BC6EB6AF9C0F Q30873974-6F33EB29-BA25-4C13-920C-AA9BB1CC74F6 Q31034031-685D22EF-DB15-48A3-A247-939BB39C1961 Q34094668-841A2C63-F2DF-4191-B659-5FD97D2E4906 Q36046525-0BC9B04D-CABF-4175-AD1F-86279DC1E63C Q36174326-3BA2A20A-2192-4F56-9A31-0FB03B29A4C1 Q36276040-6220FB71-CB8E-4F2F-89E2-D69826AA8E90 Q36301580-453352F0-A2BF-4E47-90D2-B124D9F3EAD4 Q36332532-8BE38192-2C35-4319-9B3A-4F02702164A6 Q36374541-83ECE09C-6548-4887-9801-D7CB5112D083 Q36378779-12ED4E3D-B26D-404A-9BA4-FCB11ACC5210 Q36763365-3EC6C5D7-4D1C-4261-9A75-DB7FFE6F47CA Q36818525-1EDF96D0-6A70-41E1-A653-9894A4085A1C Q37127188-21C3CF2A-E81A-41E0-A8EB-B95615BCDCB0 Q37267022-F1FDE689-545D-4E61-AC31-1D70FE666BCB Q37313955-B94B01EF-3325-4067-BA8A-29BDFC33BAF2 Q37384960-B20F0DE8-1CE0-4D68-A208-A69BFC04DB80 Q37396921-854D9AD8-8054-4B99-B8E9-7D8BB2425AC5 Q37558908-30F4ECB7-07EE-439F-8AF1-B710D4C27C76 Q37650486-6990C007-6AE4-43CE-B7F3-C56D1778648F Q38592102-150AF39F-F574-47DF-BE8F-0D4DF7AFCDD1 Q38647751-AFACA45F-87CA-44AE-94D2-EBB6F4F39970 Q38668885-E9EBFBAE-A30D-4670-9183-A06A3A2BF8C9 Q38841452-2D510539-BDE6-4667-9593-012E41CC9C68 Q38940194-4A314AD5-40EE-4635-8B39-B2A0F0F5FCE3 Q39015987-EAB9ADDA-E7D2-48D5-8B12-A4D903B75009 Q39220904-B4979B21-2328-4A06-A2FB-CECD697CBFC4 Q40016191-1044CC24-9FD4-42C9-8710-CAD64CF376E6 Q40202363-72F13BD8-7E4E-476F-B0EB-E4E3CF737A47 Q40384244-87DC83ED-E7C9-4DEB-B1DA-F69DAA619C21 Q40789536-8D99C54D-5FB8-4879-85A2-05BD3F9E8470 Q41860688-EA76E592-718E-44A4-AB55-3358D1DB420B Q42484375-F5EF2AEF-4F26-4BAF-85A2-342793611118 Q43067221-3AC1EB1B-D2D8-4CCF-81AA-9083D91B626C Q46262004-22B85059-77FE-447A-9769-8C48F1F2DAEB Q47416232-847D91D4-93C3-462B-87F0-AEB2D7C31C27 Q47683720-B181768E-28F8-4046-847B-7C01568E345E

P2860

Imaging nigral pathology and clinical progression in Parkinson's disease.

http://www.wikidata.org/entity/Q36434577

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Imaging nigral pathology and clinical progression in Parkinson's disease.

@ast

Imaging nigral pathology and clinical progression in Parkinson's disease.

@en

type

label

Imaging nigral pathology and clinical progression in Parkinson's disease.

@ast

Imaging nigral pathology and clinical progression in Parkinson's disease.

@en

prefLabel

Imaging nigral pathology and clinical progression in Parkinson's disease.

@ast

Imaging nigral pathology and clinical progression in Parkinson's disease.

@en

P1433

Q36434577-4C7BEF55-9129-4DEB-BFCD-9FE60EFF04A4

P1476

Q36434577-D5A58463-C06A-45E6-9346-FA1BD7B56E18

P2093

Q36434577-0C12C133-A7DE-45CD-B95F-C6ED3D834E2F

Q36434577-1288AC6B-8895-4AE0-A112-28309A772233

Q36434577-53B29A9B-998E-4BC4-A770-C2EE59D3A1EB

Q36434577-9B09FC19-0472-40AA-9D38-C9FB26CD17CF

Q36434577-AC86E153-DB37-4316-BA01-35FE553F7BA2

Q36434577-FCA66B78-AF0F-4EEB-BF90-6C79BFFC7FD9

P2860

Q36434577-0A2DF57C-EC8C-4CC6-86F5-3F462B25EB65

Q36434577-111671C6-8DC9-46E5-852A-9C0CEBB97B1F

Q36434577-1751183F-D4A0-4B06-A918-F5543CE0C90B

Q36434577-1AD7DC55-3DEB-42F7-8B59-76EA13484B88

Q36434577-1BC9A645-70CF-42FF-B698-C68F4A85C3CD

Q36434577-21A575C7-6890-4F23-A6D3-CA74516C2783

Q36434577-2406305C-B92C-4A20-A8B2-391E6A0FFB2E

Q36434577-2B03ED58-EF26-40C1-9E13-FFF2E1D29B92

Q36434577-2DE1BEA5-5C71-4D4B-AAE1-F3AF7F4F3FCD

Q36434577-4D200F4B-C305-4653-ADF5-98F0CA1B3895

P304

Q36434577-FCAE6DD8-ECE2-43F3-8BE3-6DCA90AFA204

P31

Q36434577-8EC08E84-A995-4C1D-89C6-0963D2107107

P356

Q36434577-775EBF09-77AB-4570-9BC8-CEF87DBB1116

P407

Q36434577-3EA61C94-38C6-4EBB-9129-E60CFC7DD616

P433

Q36434577-1D5FF2EF-C7E3-442B-B156-FAE0D96B3247

P478

Q36434577-DFC76BBC-E1D9-4618-B9F1-6A755C762FE9

P50

Q36434577-64AFC3AF-848D-4AFA-BF88-6575B3B704F1

Q36434577-C2B646C2-13D2-4A59-9DD0-F0840BD2CBD0

P577

Q36434577-FDA33DA5-54E3-41E4-A864-F01640DDA198

P5875

Q36434577-6182318A-2EDF-407B-B8FB-063F6C811A07

P698

Q36434577-29B044B8-6B16-4EA9-80D4-A6E3084ADDA3

P921

Q36434577-18D0DC8F-241F-4516-8925-42EC86B5FD7F

P932

Q36434577-500BB5BB-AA4E-407A-BA85-0AFAB55BA96A

P356

P1433

Movement Disorders

P1476

Imaging nigral pathology and clinical progression in Parkinson's disease.

@en

P2093

Guangwei Du

http://www.w3.org/2001/XMLSchema#string

Jianli Wang

http://www.w3.org/2001/XMLSchema#string

Mechelle M Lewis

http://www.w3.org/2001/XMLSchema#string

Michele L Shaffer

http://www.w3.org/2001/XMLSchema#string

Qing X Yang

http://www.w3.org/2001/XMLSchema#string

Suman Sen

http://www.w3.org/2001/XMLSchema#string

P2860

High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease

Core assessment program for intracerebral transplantations (CAPIT)

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

Iron, brain ageing and neurodegenerative disorders

Ageing and Parkinson's disease: substantia nigra regional selectivity

User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability

Imaging iron stores in the brain using magnetic resonance imaging.

Relaxation induced by ferritin and ferritin-like magnetic particles: the role of proton exchange.

Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease.

Anatomy of the substantia nigra and subthalamic nucleus on MR imaging.

P304

1636-1643

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.25182

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231176221

http://www.w3.org/2001/XMLSchema#string

P698

23008179

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

3510346

http://www.w3.org/2001/XMLSchema#string